Discussion on Improving the Regulation of Off -label Drug Use in China Based on France’s Experience
Wu Zhipeng, Liang Yi
Chinese Pharmaceutical Affairs . 2023, (4): 376 -381 .  DOI: 10.16153/j.1002-7777.2023.04.002

京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.